Rhyl's Royal Alexandra Hospital plans expected after 12-year delay
In 2013, Mark Drakeford, the then health minister, approved initial proposals to develop a new hospital on the site of the Royal Alexandra - which was built in the 1890s.The integrated community hospital scheme was supposed to be completed in 2016.It would include dental clinics, 30 in-patient beds and 18 in-patient beds for older people with mental health problems, as well as an x-ray department, ultrasound facilities and a pharmacy.Twelve years on, the site is still awaiting development.The health board has said it intends to submit revised plans by the end of the month. The plans are expected to be scaled down from the original proposals.
Local resident Christine Gardiner said: "I just think it should be used in conjunction with Glan Clwyd at Bodelwyddan, because the waiting times there are terrible, the parking's shocking, and it would be more handy for local people."Laura Everett, 41, said the Royal Alexandra was "extremely important, especially with the health system as it is at the moment"."I feel like the more local places we have... the better," she said. "I feel like it could be used a lot more to lessen the load off the actual main hospitals. We need it. It's vital."Lifelong Rhyl resident Michael Jones said: "It is frustrating. You don't know what's happening with the place. "You hear all these stories, the changes, the improvements, but nothing seems to be happening at the moment. We need to know what's going on."
Darren Millar, Member of the Senedd for Clwyd West, said residents in Rhyl and surrounding areas were "fed up waiting" for the site to be developed, and believed the new proposal may be for 14 beds."We're expecting the announcement to say that there's going to be far fewer beds at the hospital than was originally anticipated, possibly fewer than half of the beds... and that means that we're not going to take the pressure of Glan Clwyd Hospital down the road, where we know that the problems have got even worse over the past 12 years," he said. He added that it was "not good enough" and it would be "too late"."What we need is to get back to those original plans and make sure that those promises to the people of north Wales are actually delivered."
Mr Millar said any proposals short of the original plans "would show yet again the massive north-south divide and the fact that north Wales is being short-changed".He added the original 30 beds would help ease pressures elsewhere in the NHS, but "14 beds isn't a spittle in the bucket"."If anything, we need that original 30 beds to be increased, not decreased."
The health board has been asked to comment. On its website, it said it hoped to submit plans, which will include a bedded unit and a minor injuries and ailments unit, by the end of this month.Those plans would need approval by the health board itself, and then the Welsh government would be asked for approval and funding.The Welsh government said it was awaiting a revised business case to be submitted.Plaid Cymru's health spokesperson Mabon ap Gwynfor said: "The need for a new Royal Alex [Alexandra] is plain for all to see and would help patients across the region, yet this government has twiddled its thumbs for far too long with patients suffering as a consequence."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
11 minutes ago
- Reuters
Novo Nordisk debuts Wegovy in South Africa as weight-loss drugs race gathers pace
JOHANNESBURG, Aug 14 (Reuters) - Danish drugmaker Novo Nordisk ( opens new tab introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's (LLY.N), opens new tab Mounjaro which launched in the country eight months ago. South Africa has the continent's fourth-highest number of adults with diabetes, according to the International Diabetes Federation, making it a key growth opportunity. "One in two adults right now in South Africa is living with excess weight or obesity," Sara Norcross, general manager of Novo Nordisk South Africa, said at the launch event. "Wegovy is the first and only once-weekly GLP-1 right now that is registered for weight management," she added, referring to a class of therapies known as GLP-1 receptor agonists that make people feel fuller for longer. Novo already sells Ozempic in South Africa for diabetes treatment. Eli Lilly also sells Mounjaro only for the treatment of Type 2 diabetes in South Africa, through Aspen Pharmacare (APNJ.J), opens new tab, though some people take the drug for weight loss. Wegovy, already launched in 35 countries, will be available in five dose strengths in South Africa, and its pricing will be disclosed next week, the company said. Mounjaro, also a once-weekly injectable treatment, is priced from 3,400 rand ($194) for four vials of its lowest dose, depending on the pharmacy or clinic. Novo plans to expand Wegovy into other African markets, Norcross told Reuters, as part of a push to boost sales outside the United States. "I believe it's going to be launching in Egypt soon, and registrations are being submitted for other countries too," she said. The company generates the bulk of its profits from Wegovy sales in the U.S., where it competes with Eli Lilly's Zepbound and Mounjaro. More than a billion people have obesity worldwide, according to the World Health Organization, and around 70% of them live in low and middle-income countries, highlighting the potential impact of weight-loss drugs like Wegovy in underserved markets. In South Africa alone, around 20 million people are overweight or obese, though less than 1% currently receive treatment, Norcross said. The WHO plans to back the use of weight-loss drugs to treat obesity in adults for the first time, Reuters reported in May, signalling a significant shift in the agency's stance on tackling the global health challenge. ($1 = 17.5258 rand)
BBC News
41 minutes ago
- BBC News
Welsh teenager researching medical cannabis to study at Oxford
A teenager who has secured a spot at the University of Oxford says the way cannabis has helped her mother's condition "opened my eyes to its medical potential".Ariana Howells, 17, from Barry in Wales, who achieved three A*s and one A in A-level biology, chemistry, maths, and English literature, plus 97% in her Extended Project Qualification, will now take her place at St Hilda College to study interest in medical cannabis has highlighted the drug's promise, as well as gaps in existing said that despite "stigma and strong media opinions", science was about "being open to where the evidence leads". Ariana, who is a scholarship student at Cardiff Sixth Form College, examined the extent THC, a component of cannabis, can "negatively affect sleep architecture" as part of her studies."There were only seven studies worth citing," Ariana said."I expected clearer answers, but what I found was a real need for more in-depth, unbiased research. "This is something I want to keep exploring at university and beyond."Her mother lives with Crohn's disease, an incurable chronic inflammatory bowel believes medical cannabis has played a crucial role in improving her quality of parents run Cannabis Clinic Cardiff where the teenager has spent the last two years helping with admin and learning about the evolving science behind the plant-based treatment."Seeing my mum's condition and the way cannabis helped her and the patients who visit our clinic really opened my eyes to its medical potential," she said."My dad is also a senior psychiatrist, so I've grown up in a household where science and care come together."Outside of school, she has earned gold in the Biology Olympiad and is a competitive ice preparation for Oxford, Ariana plans to channel her energy into drug development and mental health research, and she is especially interested how medical cannabis could one day transform care."There's still stigma and strong media opinions," she said."But science is about asking difficult questions and being open to where the evidence leads." You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.
The Independent
an hour ago
- The Independent
Maine clinics hope to get blocked Medicaid funds restored as they sue Trump administration over cuts
A network of clinics that provides health care in Maine is expected to ask a judge Thursday to restore its Medicaid funding while it fights a Trump administration effort to keep federal money from going to abortion providers. President Donald Trump's policy and tax bill, known as the ' big beautiful bill,' blocked Medicaid money from flowing to Planned Parenthood, the nation's largest abortion provider. The parameters in the bill also stopped funding from reaching Maine Family Planning, a much smaller provider that offers health care services in one of the poorest and most rural states in the Northeast. A federal judge ruled last month that Planned Parenthood clinics around the country must continue to be reimbursed for Medicaid funding as the provider wrangles with the Trump administration over efforts to defund it. Maine Family Planning filed a federal lawsuit last month seeking to restore reimbursements. Lawyers and representatives for Maine Family Planning say its 18 clinics provide vital services across the state including cervical cancer screenings, contraception and primary care to low-income residents. They also say the funding cut occurred even though Medicaid dollars are not used for its abortion services. 'Without Medicaid, MFP will be forced to stop providing all primary care for all patients — regardless of their insurance status — by the end of October,' the organization said in a statement, adding that about 8,000 patients receive family planning and primary care from the network. It also said many Maine Family Planning clinics 'provide care in very rural areas of the state where there are no other health care providers, and around 70% of their patients rely exclusively on MFP and will not see any other health care provider in a given year.' In court documents, Anne Marie Costello, deputy director for the Center for Medicaid & CHIP Services, called the request to restore funding 'legally groundless' and said it 'must be firmly rejected.' 'The core of its claim asks this Court to revive an invented constitutional right to abortion — jurisprudence that the Supreme Court decisively interred — and to do so in a dispute over federal funds,' Costello said. While advocates of cutting Medicaid for abortion providers focused on Planned Parenthood, the bill did not mention it by name. Instead it cut off reimbursements for organizations that are primarily engaged in family planning services — which generally include things such as contraception, abortion and pregnancy tests — and received more than $800,000 from Medicaid in 2023. The U.S. Senate's parliamentarian rejected a 2017 effort to defund Planned Parenthood because it was written to exclude all other providers by barring payments only to groups that received more than $350 million a year in Medicaid funds. Maine Family Planning asserts in its legal challenge that the threshold was lowered to $800,000 this time around to make sure Planned Parenthood would not be the only entity affected. It is the only other organization that has come forward publicly to say its funding is at risk. Planned Parenthood's legal fight with the Trump administration over Medicaid funding is still in the court system also.
